Can a smartphone replace the clinic? new study tests At-Home kidney care
NCT ID NCT06094920
First seen Feb 16, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study tested whether people with type 2 diabetes and early kidney disease can manage their medications from home. Twelve participants took empagliflozin and, if needed, added finerenone to lower protein in their urine. They measured their own blood pressure, weight, and collected urine and blood samples at home. The goal was to see if this remote approach is practical and effective for personalized treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ZorgGroep Twente
Almelo, Overijssel, 7609PP, Netherlands
Conditions
Explore the condition pages connected to this study.